Johnson & Johnson signed a $456.2 million deal to develop a COVID-19 vaccine and a $148.4 million deal to develop antiviral therapies.
Moderna also was awarded a $483 million deal to develop a COVID-19 vaccine.
Other companies have secured nine-figure deals for medical supplies, including ventilators and N95 face masks, Bloomberg Law reported.
The top 20 recipients of U.S. COVID-19 contracting dollars and what they were contracted for:
- Royal Philips — ventilators
- Johnson & Johnson — vaccine
- Hamilton Medical — ventilators
- Moderna — vaccine
- Vyaire Holding — ventilators
- GE — ventilators
- Asahi Kasei — ventilators
- RER Financial Group — SBA analysis
- Dell Technologies — computers
- 3M — N95 masks
- Honeywell — N95 masks
- ACS — NY Care Facility
- Global Medical Response — transport
- Aecom — NY Care Facility
- Airboss of America — respirators
- Regeneron — drug development
- FedEx — shipping
- Panthera Worldwide — N95 masks
- Mitchell International — ventilators
- Colossal Contracting — computers
Read the full article here.
More articles on pharmacy:
Largest hydroxychloroquine study to date finds no benefit for COVID-19
NIH panel releases COVID-19 treatment, pharmaceutical intervention guidelines
How 13 drugmakers have responded to the COVID-19 pandemic
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
